HsinLiang Lee - Ainos Chief Officer
| AIMD Stock | USD 0.45 0.02 4.26% |
Executive
HsinLiang Lee is Chief Officer of Ainos Inc
| Age | 53 |
| Address | 8880 Rio San Diego Drive, San Diego, CA, United States, 92108 |
| Phone | 858 869 2986 |
| Web | https://www.ainos.com |
HsinLiang Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of HsinLiang Lee against Ainos stock is an integral part of due diligence when investing in Ainos. HsinLiang Lee insider activity provides valuable insight into whether Ainos is net buyers or sellers over its current business cycle. Note, Ainos insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ainos'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
HsinLiang Lee over a year ago Acquisition by HsinLiang Lee of 8000 shares of SemiLEDS subject to Rule 16b-3 |
Ainos Management Efficiency
The company has return on total asset (ROA) of (0.2802) % which means that it has lost $0.2802 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.706) %, meaning that it created substantial loss on money invested by shareholders. Ainos' management efficiency ratios could be used to measure how well Ainos manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -4.06. The current year's Return On Capital Employed is expected to grow to -0.41. At present, Ainos' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 219.3 K, whereas Other Assets are forecasted to decline to about 70.1 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jill Mason | Orthofix Medical | N/A | |
| Robert Thomson | Artivion | 54 | |
| Leah Akin | Neuropace | N/A | |
| Marshall MD | Artivion | 67 | |
| Daniel JD | Orthopediatrics Corp | 54 | |
| Michael Soule | Movano Inc | N/A | |
| Ben Joseph | Anika Therapeutics | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 64 | |
| Jennifer Englund | CVRx Inc | N/A | |
| Julie Andrews | Orthofix Medical | 53 | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Jonelle Burnham | CVRx Inc | 53 | |
| Lucas Vitale | Orthofix Medical | 47 | |
| Joel Batts | Orthopediatrics Corp | N/A | |
| Stacy Salvi | Movano Inc | N/A | |
| Phil Kelly | Movano Inc | 65 | |
| Dylan John | Neuropace | N/A | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Mark Namaroff | Anika Therapeutics | 61 | |
| Craig Palmer | CVRx Inc | 47 | |
| Irina Ridley | Neuropace | 38 | |
Management Performance
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 |
Ainos Inc Leadership Team
Elected by the shareholders, the Ainos' board of directors comprises two types of representatives: Ainos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ainos. The board's role is to monitor Ainos' management team and ensure that shareholders' interests are well served. Ainos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ainos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| HuiLan Wu, Chief Officer | ||
| HsinLiang Lee, Chief Officer | ||
| Lawrence Lin, Executive Operations | ||
| ChihHeng Lu, Director Developoment | ||
| ChunHsien Tsai, President Board | ||
| MengLin Sung, Chief Officer | ||
| John Esq, Corp Counsel |
Ainos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ainos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (359.85) % | ||||
| Current Valuation | 13.56 M | ||||
| Shares Outstanding | 13.84 M | ||||
| Shares Owned By Insiders | 65.50 % | ||||
| Shares Owned By Institutions | 1.10 % | ||||
| Number Of Shares Shorted | 143.25 K | ||||
| Price To Book | 0.36 X | ||||
| Price To Sales | 158.68 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ainos Inc is a strong investment it is important to analyze Ainos' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ainos' future performance. For an informed investment choice regarding Ainos Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ainos Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ainos. If investors know Ainos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ainos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.71) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0.58) | Return On Assets (0.28) | Return On Equity (0.71) |
The market value of Ainos Inc is measured differently than its book value, which is the value of Ainos that is recorded on the company's balance sheet. Investors also form their own opinion of Ainos' value that differs from its market value or its book value, called intrinsic value, which is Ainos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ainos' market value can be influenced by many factors that don't directly affect Ainos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ainos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ainos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ainos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.